Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 21, 2007

King Pharmaceuticals’ Facility to Manufacture Syphilis Drug Approved

  • The FDA approved King Pharmaceuticals’ new manufacturing and production facility in Rochester, MI, for its Bicillin® product line.

    According to the company, the recent Sexually Transmitted Diseases Treatment Guidelines issued in 2006 by the CDC recommends penicillin G as the preferred treatment of all stages of syphilis. Bicillin L-A, administered via deep intramuscular injection, has been used for more than 60 years to cure syphilis and prevent sexual transmission, notes Eric J. Bruce, chief technical operations officer, King Pharmaceuticals.”

    To streamline the ease and use of Bicillin L-A, continues Bruce, King is now using the Becton Dickinson Hypack™ Luer-Lok™ syringe system with the Eclipse™ safety-cover needle.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »